A complete screening of the CFTR gene by DGGE and DNA sequencing was perfor
med in patients with sarcoidosis. In 8/26 cases, missense and splicing CFTR
gene mutations were found, a significant difference over controls (9/89) f
rom the same population (P = 0.014). The odds ratio for a person with a CFT
R gene mutation to develop the disease is 3.95 (1.18 < OR < 13.26). Seven d
ifferent CFTR gene mutations were observed: R75Q, R347P, 621 + 3 A/G, 1898
+ 3 A/G, L997F, G1069R, and a novel mutation which was detected in this stu
dy, 1991V. R75Q mutation was present in 3/26 patients, a significant increa
se (P = 0.01) in cases over controls, indicating its preferential associati
on with sarcoidosis. A trend towards disease progression was observed in pa
tients with CFTR gene mutations compared to patients without mutations. The
se data suggest that CFTR gene mutations predispose to the development of s
arcoidosis.